Current Issue

Vol 9 No 3 (2024): May-June

Case Report(s)

  • XML | PDF | downloads: 4 | views: 9 | pages: 88-92

    Retained products of conception (RPOC) occur when fragments of the placenta or decidual tissue remain in the uterus, often leading to postpartum hemorrhage. Early and accurate diagnosis, aided by ultrasonography, is essential for appropriate management and prevention of complications. We report a case of a 22-year-old woman admitted to our tertiary medical department with irregular vaginal bleeding and abdominal pain. She had no significant past medical history. Abdominal ultrasonography revealed a normal-sized uterus with homogeneous myometrial echogenicity. However, a heterogeneous echogenic mass, exhibiting considerable vascularity and feeding vessels from the endometrial cavity, was observed in the cervix. Additionally, the patient’s beta human chorionic gonadotropin (Beta-HCG) concentration was positive, with a titer of 201 µ/l, despite her claim of being a virgin. Subsequently, the patient underwent hysteroscopy, during which an infected and malodorous lesion was removed from the uterus, confirming the diagnosis of RPOC. In follow-up assessments, she experienced no complications. To the best of our knowledge, no cases of RPOC located in the cervix have been reported previously, as RPOC is typically expected to be found in the endometrial cavity. This study aims to share our experience in considering the differential diagnosis of RPOC as cervical lesions and highlights the importance of ultrasonography in early pregnancy management.

  • XML | PDF | downloads: 7 | views: 9 | pages: 93-98

    Non-puerperal uterine inversion (NPUI) is an extremely rare condition. Our case is the second, where a young female (adolescent age group) presented with uterine inversion, and is the first without any identifiable cause of uterine inversion. Her chief complaints were chronic menorrhagia, abdominal pain, and episodes of acute urinary retention. Most of the reported cases have identifiable etiology for the inversion. The reporting of this case is worthwhile because of its rarity in such age groups and even without any defined cause (spontaneous occurrence), making the diagnosis of uterine inversion in this condition challenging, particularly in this very young age. In our case, she was initially misdiagnosed as having a cervical polyp clinically and radiologically,
    especially on ultrasonography (USG). Finally, it was diagnosed as uterine inversion by magnetic resonance imaging (MRI) of the pelvis and retrospective evaluation of USG. Magnetic resonance imaging (MRI) thus plays a pivotal role in the diagnosis of uterine inversion. Treatment of uterine inversion is either mostly by manual repositioning, and if not possible, surgery is contemplated.

  • XML | PDF | downloads: 8 | views: 11 | pages: 99-103

    The impact of anxiety and injuries caused by severe stress can contribute to the manifestation of more severe disorders in children. The authors of this article have reported a case involving a five-and-a-half-year-old child who formed an insecure attachment or reliance on his father after experiencing several instances of anxiety
    attacks (panic attacks). The child was assessed utilizing the Conner’s QEEG test (Conner Rating Scale-Revised) parent version and the Spence Children’s Anxiety Scale (SCAS). Subsequently, a treatment plan incorporating drug administration, Loretta neurofeedback, and psychological counseling was implemented. Notably, session
    three of QEEG demonstrated a decline in anxiety levels. However, no changes were observed in the child’s insecure attachment and reliance on the father. Hence, adopting a trans-diagnostic and dimensional approach is crucial when assessing uncommon cases and developing treatment protocols tailored to each disorder.

  • XML | PDF | downloads: 5 | views: 15 | pages: 104-107

    A 15-year-old male presented at a neurosurgeon’s office following a traffic accident. A CT scan revealed bone deficiency in the temporoparietal area. The surgical solution involved implanting a 3D-printed prosthesis into the skull. Axial 3D created the model using stereolithography 3D printing technology with Poly Methyl Methacrylate
    (PMMA). The use of 3D printing as a surgical aid is gaining popularity. Our experience with the presurgical model demonstrates its utility in individualized surgical planning for skull defects.

  • XML | PDF | downloads: 7 | views: 6 | pages: 108-113

    In the present case report, we have found a novel variant for TRIOBP in a patient with congenital hearing loss. The patient is an 8-year-old female with hearing loss, the first child of consanguineous parents. To identify the underlying genetic defect, whole genome sequencing was performed. Carrier screening of the parents was
    also conducted. The results showed a homozygous autosomal recessive missense c.5849C>T (p.Pro1950Leu) variant in exon 16 of the TRIOBP gene. To our knowledge, this variant has not been previously reported as either a pathogenic or a benign variant. The novel TRIOBP variant found in the present study broadens the range of TRIOBP mutations implicated in hearing loss. Accordingly, the results of this study may be important for genetic counseling.

  • XML | PDF | downloads: 5 | views: 16 | pages: 114-118

    Crigler-Najjar syndrome type II is a metabolic disorder stemming from mutations in the UGT1A1 gene, resulting in heightened levels of unconjugated bilirubin. Here is a case report of a 17-year-old male patient with minor thalassemia and G6PD deficiency who was referred due to worsening jaundice. He has had a history of lifelong jaundice, which has intensified over the past year and a half. Subsequently, the patient was diagnosed with Crigler-Najjar type II based on his medical history, clinical examination, and laboratory findings. Furthermore, the patient’s positive response to phenobarbital treatment confirmed the diagnosis. Consequently, it is imperative to consider CriglerNajjar syndrome in cases of unexplained unconjugated hyperbilirubinemia.

  • XML | PDF | downloads: 6 | views: 22 | pages: 119-124

    Superior vena cava syndrome (SVCS) is a clinical condition caused by the obstruction of venous return through the superior vena cava (SVC). This report presents a 71-year-old male diagnosed with central lung cancer and chronic obstructive pulmonary disease (COPD) complicated by SVCS. The report details his clinical presentation, diagnostic
    workup, and management, including chemotherapy and symptomatic treatment. SVCS can significantly affect patient outcomes, especially in cases of malignancy, and requires timely intervention.

  • XML | PDF | downloads: 3 | views: 8 | pages: 125-132

    Sudden sensorineural hearing loss (SSNHL) as the initial manifestation of multiple myeloma (MM) is rare. We present a 45-year-old woman with hyperviscosity syndrome (serum viscosity of 10.2 cP) from MM who presented with hearing disturbance that responded dramatically to plasma exchange with saline and intratympanic steroid
    treatment. Serum protein electrophoresis confirmed the presence of a monoclonal band, and bone marrow biopsy showed a hypercellular marrow with 90% plasma cells, which demonstrated lambda monoclonal restriction.

  • XML | PDF | downloads: 4 | views: 8 | pages: 133-136

    Pulmonary spindle cell carcinoma (PSCC) is a rare and highly aggressive form of nonsmall cell lung cancer with sarcomatoid differentiation. It poses significant diagnostic challenges due to its histological resemblance to other malignancies, including inflammatory myofibroblastic tumors. This case report details the clinical presentation,
    histopathological findings, and treatment of a patient with PSCC, to further elucidate the clinical features, diagnosis, and management of this rare tumor.

  • XML | PDF | downloads: 13 | views: 14 | pages: 137-140

    Sertraline is classified as a selective serotonin reuptake inhibitor (SSRI) that is extensively employed in the management of a range of psychiatric conditions, encompassing major depressive disorder and anxiety disorders. While the overall incidence of hair loss is not extensively documented, it is recognized as a possible
    cutaneous reaction to SSRIs, including sertraline. In the present study, we report the case of a 16-year-old Iranian female of Persian ethnicity who had been treated for panic disorder. She developed severe hair loss
    two weeks post-initiation of treatment with sertraline 50 mg per day. She stopped the medication after two months when she had lost 50% of her hair. The exact mechanism remains unclear, but it is suggested that SSRIs like sertraline may induce hair loss by pushing hair follicles into the telogen phase prematurely, leading to diffuse hair shedding. Management typically involves dose adjustment or discontinuation of sertraline, which has been shown to resolve hair loss in multiple cases. Understanding this phenomenon is crucial for both patients and healthcare providers. Although rare, this side effect can considerably affect a patient’s overall quality of life and compliance with therapeutic regimens.

View All Issues